BTK and primary central nervous system lymphoma: Consistent with the crucial role of aberrant B-cell receptor signaling pathways in PCNSL, Bruton tyrosine kinase inhibitors (BTKis) have dramatically improved the treatment efficacy in rrPCNSL (11).